General practice leaders are backing the Government’s move to make cervical screening free for eligible women, but they are warning that the policy will only work if the clinics expected to deliver it are properly funded.
GenPro, which represents owners and providers of general practices and urgent care centres across New Zealand, says primary care must be directly involved in designing the contractual and funding arrangements for the expanded screening programme.
The organisation supports removing the cost barrier for women aged 25 to 69, but says “free to the patient” cannot be allowed to mean “subsidised by the practice”.
That distinction goes to the heart of the issue.
General practices already provide much of New Zealand’s cervical screening. If more women come forward once fees are removed, practices will need enough clinical time, staff capacity and administrative support to handle the additional demand.
GenPro says those costs need to be recognised from the beginning.
Why the policy matters
Cervical screening is one of the most effective tools available for identifying people at risk of developing cervical cancer before the disease becomes advanced.
New Zealand’s screening system has changed significantly in recent years with the introduction of HPV testing, including self-testing options for many participants.
The Government’s decision to remove patient charges has the potential to eliminate another major barrier.
GenPro Chair Dr Chambers said the organisation welcomed that objective.
“We welcome the Government’s decision to remove the cost barrier to cervical screening for eligible women,” he said.
He said the change could help increase screening participation and, together with HPV vaccination, move New Zealand closer towards eliminating cervical cancer.
That is the public-health opportunity.
The operational question is how the service will actually be delivered.
General practices say the work goes well beyond taking a test
From a patient’s perspective, cervical screening may appear to be a relatively straightforward appointment.
From the provider’s side, however, there is considerably more involved.
GenPro says the funding model needs to recognise costs including:
- clinical staff time
- administrative work
- booking and recalling patients
- following up people who miss appointments
- managing results
- maintaining clinical capacity
- supporting patients who require further investigation
Those functions become particularly important when programmes are trying to reach people who have not participated regularly in screening.
Simply paying for the moment a sample is collected does not necessarily cover the wider work required to run an effective screening programme.
“General practice cannot subsidise” a national programme
Dr Chambers said practices should not be expected to absorb those costs themselves.
“But if screening is to be free for patients, the Government needs to ensure the service is properly funded for the general practices that deliver it,” he said.
“General practice cannot subsidise a free national screening programme.”
That is likely to become the central point in discussions between primary-care providers and the Government.
A programme can technically be free for patients while shifting the financial pressure somewhere else in the health system.
If general practices are paid less than the true cost of providing the service, they may end up absorbing the difference.
For clinics already dealing with workforce shortages, growing patient demand and financial pressure, that could become difficult to sustain.
Who is eligible?
The proposed free cervical screening programme is aimed at eligible women aged 25 to 69.
That age range broadly aligns with New Zealand’s national cervical screening framework.
The removal of patient charges is intended to make screening easier to access, particularly for people who may have delayed or avoided appointments because of cost.
The policy could therefore have the greatest impact among groups who currently participate in screening at lower rates.
But improving equity requires more than removing one fee.
Patients still need appointments to be available.
Practices need staff.
People may need culturally appropriate support, translation or additional follow-up.
Some may need help understanding self-testing options or the importance of further investigation after an abnormal result.
That is why GenPro is arguing that frontline providers should help design the system rather than being handed the final model after key decisions have already been made.
The success of free screening depends on capacity
Removing fees could increase demand.
That is exactly what the policy is supposed to achieve.
But increased demand is only beneficial if the health system can absorb it.
A poorly designed funding model could create longer waits or additional pressure on practices already struggling to meet routine demand.
The challenge is therefore not simply getting more people to request screening.
It is ensuring they can receive it promptly and that abnormal results are followed through properly.
Screening programmes succeed through a chain of actions.
People need to participate.
Samples need to be processed.
Results need to be communicated.
Higher-risk patients need further assessment.
Treatment needs to follow where necessary.
Any weak point in that chain can reduce the value of the programme.
Why cervical screening remains important in New Zealand
Cervical cancer is largely preventable when HPV vaccination and effective screening work together.
Most cervical cancers are linked to persistent infection with high-risk forms of human papillomavirus.
Vaccination reduces the risk of acquiring the HPV types responsible for most cervical cancers.
Screening provides another layer of protection by identifying HPV infection or cellular changes before cancer develops.
New Zealand has increasingly moved towards HPV-based screening because it can detect risk earlier and allows self-testing for many participants.
That development has already changed the nature of cervical screening.
The next challenge is ensuring cost does not remain an obstacle.
Free screening could improve equity
One reason the Government’s policy is potentially significant is that cervical cancer does not affect all communities equally.
Historically, Māori and Pacific women have faced poorer cervical cancer outcomes and lower screening coverage than some other population groups.
Cost is only one reason for those differences.
Other barriers can include:
- difficulty accessing primary care
- transport
- time away from work
- childcare responsibilities
- previous negative healthcare experiences
- cultural barriers
- discomfort with the screening process
- limited awareness of available options
Removing fees cannot solve all of those problems.
But it can eliminate one.
The effectiveness of the policy will depend on whether it is combined with practical outreach and enough primary-care capacity to reach people who have previously been missed.
Self-testing has already changed the conversation
HPV self-testing has made cervical screening more accessible for many people who may have been reluctant to undergo a traditional cervical sample.
For eligible participants, a self-collected vaginal swab can often be used as the first step in HPV screening.
That can be more comfortable and less invasive.
But self-testing does not remove the need for general practice.
Patients may still need advice, follow-up, clinical assessment and further testing depending on their results.
That is another reason GenPro says the funding discussion needs to consider the entire service rather than just the test itself.
GenPro wants a seat at the table before contracts are finalised
Dr Chambers said general practice should be directly involved in developing the contractual arrangements.
“General practice knows what’s required to deliver screening safely and effectively in communities across New Zealand,” he said.
He argued that because GenPro represents organisations that own and operate practices, it should be involved before the model is locked in.
The organisation says early consultation should help avoid policies that look workable at a central-government level but become difficult when implemented in individual clinics.
That argument extends beyond cervical screening.
GenPro has made early consultation one of its broader policy priorities for restoring general practice.
This reflects a wider tension in primary healthcare
The dispute is familiar.
Governments frequently announce new or expanded primary-care services because general practices are the most obvious place to deliver them.
But each additional responsibility competes for the same limited resources.
GP appointments.
Nursing time.
Reception staff.
Consultation rooms.
Administrative capacity.
The issue is rarely whether the new service itself is worthwhile.
The question is whether enough money and workforce capacity accompany it.
If not, one programme can unintentionally squeeze another.
That is particularly important in general practice because clinics do not have unlimited ability to expand staffing at short notice.
The Government has an opportunity to get the design right
The free-screening policy has a strong public-health rationale.
Reducing barriers to cervical screening should help more people participate.
But the implementation stage may determine whether the policy achieves its potential.
A strong model would need to do several things at once.
It would have to keep screening free for patients.
It would need to fairly reimburse providers.
It would need to recognise the additional work involved in reaching overdue participants.
And it would need to support follow-up where screening identifies increased risk.
If those elements are properly funded, the policy could improve both participation and health outcomes.
If they are not, practices may end up carrying additional work without enough resources.
Free does not mean costless
That is the most important distinction in this debate.
Making cervical screening free is a decision about who pays.
It does not make the service itself costless.
Doctors, nurses and administrative staff still need to be paid.
Clinics still have overheads.
Follow-up still takes time.
Laboratories still process tests.
The policy shifts the cost away from individual patients, which may be entirely justified on public-health grounds.
But the funding needs to follow the service.
Otherwise the pressure simply moves from the patient to the provider.
What happens next will matter more than the announcement
GenPro says it wants to work constructively with the Government rather than oppose the initiative.
Its concern is implementation.
That creates an opportunity for the Government to involve primary-care providers before contractual arrangements are finalised.
Done well, free cervical screening could remove an important financial barrier, improve participation and contribute to the long-term goal of preventing cervical cancer.
But the policy will ultimately be judged not by whether an appointment is advertised as free.
It will be judged by whether eligible women can actually access screening, whether practices have enough capacity to provide it and whether people who need further care are successfully followed through the system.
The Government has taken the first step by removing the cost barrier.
The next challenge is making sure the health system delivering the programme is strong enough to carry it.
Source: GenPro media statement.